Oxiglutatione

奥谷胱甘肽

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxiglutatione
Drug Alias Name氧化型谷胱甘肽Glutathione disulfideBSS PLUS
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsOphthalmologic surgical proceduresPoisoningHypoxia +[4] 
Global Approved IndicationsOphthalmologic surgical proceduresPoisoningHypoxia +[4] 
Approved Indications in ChinaPoisoningHypoxiaLiver Diseases
Original Approved Country/TerritoryUnited States
Original Approved Date1981/10/28
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co LtdSenju Pharmaceutical Co LtdAlcon
China Registration ClassN/A

Develop Information

Active CompaniesYaopharma Co LtdAlcon Laboratories Inc
Inactive CompaniesAlcon Pharmaceuticals Ltd
Active IndicationsOphthalmologic surgical proceduresPoisoningHypoxia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeV03AB
Related LinksKEGG